Redeye: Bredband2 - Promising Outlook
Redeye makes positive estimate revisions on the back of Bredband2’s strong Q3 2023 report that beat our estimates across the board. Most notably, we raise EBIT projections by 7-6% for 2023e-2024e, as the company’s margin expansion has been more successful than our expectations. Our positive estimate revisions entail a higher base case valuation.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/